Glaukos Corporation (GKOS)
NYSE: GKOS · IEX Real-Time Price · USD
99.48
-0.63 (-0.63%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Glaukos Revenue

In the year 2023, Glaukos had annual revenue of $314.71M with 11.26% growth. Revenue in the quarter ending December 31, 2023 was $82.37M with 15.64% year-over-year growth.

Revenue (ttm)
$314.71M
Revenue Growth
+11.26%
P/S Ratio
15.86
Revenue / Employee
$346,980
Employees
907
Market Cap
4.99B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.71M31.85M11.26%
Dec 31, 2022282.86M-11.15M-3.79%
Dec 31, 2021294.01M69.05M30.70%
Dec 31, 2020224.96M-12.03M-5.07%
Dec 31, 2019236.98M55.71M30.73%
Dec 31, 2018181.28M22.02M13.83%
Dec 31, 2017159.25M44.86M39.21%
Dec 31, 2016114.40M42.70M59.55%
Dec 31, 201571.70M26.11M57.28%
Dec 31, 201445.59M24.64M117.64%
Dec 31, 201320.95M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
Organon & Co. 6.26B
Option Care Health 4.43B
Bausch + Lomb 4.15B
R1 RCM 2.25B
Halozyme Therapeutics 829.25M
CRISPR Therapeutics AG 371.21M
Blueprint Medicines 249.38M
Revenue Rankings